Results 231 to 240 of about 278,879 (377)

Tuberculosis-Associated Paradoxical Immune Reconstitution Inflammatory Syndrome in an HIV-Negative Patient Presenting With a Recurrent Pleural Effusion Managed With Prednisolone: A Case Report. [PDF]

Clin Case Rep
Gissa SB, Gemechu AG, Tilahun S.
europepmc   +1 more source

Quantitation in men of suppressive effects of fluocortolone and prednisolone by evaluation of diurnal rhythms of serum cortisol [PDF]

, 1970
Boss, M., Gerb, A. C., Kluge, F., Müller, O. A., Scriba, Peter Christian   +4 more
core   +1 more source

PENGARUH PENGGUNAAN VARIASI KONSENTRASI AVICEL PH-101 PADA FORMULA TABLET PREDNISOLONE

, 2019
hilda suherman
openalex   +2 more sources

A rare case of invasive thymoma presented a dramatic response to low-dose prednisolone as a single-drug therapy.

, 2021
Masaki Hanibuchi, Atsuro Saijo, Atsushi Mitsuhashi, Tatsuya Kajimoto, Tetsuya Kitagawa   +4 more
openalex   +2 more sources

Internal closure of a posterior perforation using amniotic membrane: A novel surgical technique

Acta Ophthalmologica, EarlyView.
J. S. Suwandi, B. A. van der Wel, E. H. C. van Dijk, S. S. Manning, M. Manzulli, P. Geeraert, S. van Romunde, K. Faridpooya   +7 more
wiley   +1 more source

Tafasitamab as Monotherapy or in Combination in Japanese Patients With B‐Cell Non‐Hodgkin Lymphoma: Results From the Phase 1b J‐MIND Study

Cancer Science, EarlyView.
J‐MIND evaluated the safety and tolerability of tafasitamab, a CD19‐targeting monoclonal antibody, alone or in combination with other therapies in Japanese patients with B‐cell non‐Hodgkin lymphoma (NHL). Most common treatment‐emergent adverse events across all groups were hematological, and no serious tafasitamab treatment‐related or fatal adverse ...
Koji Izutsu, Noriko Fukuhara, Junichiro Yuda, Youko Suehiro, Shigeru Kusumoto, Marie‐Laure Casadebaig, Kazumi Suzukawa, Kentaro Fukushima   +7 more
wiley   +1 more source

A Case of Acquired Factor V Deficiency in a Hemodialysis Patient: A Case Report With Literature Review. [PDF]

IJU Case Rep
Sugino A, Miyazawa Y, Harashima S, Shimizu Y, Kajita M, Miyazawa Y, Ogawa Y, Handa H, Sekine Y, Suzuki K.   +9 more
europepmc   +1 more source

Assessment of hyaluronic acid-conjugated pH-sensitive liposomes for prednisolone delivery to activated macrophages

Andreia Marinho, Salette Reis, Cláudia Nunes   +2 more
openalex   +2 more sources

Polymyalgia rheumatica. Abrupt and gradual withdrawal of prednisolone treatment, clinical and laboratory observations. [PDF]

, 1977
W. Esselinckx, S. M. Doherty, A. St. J. Dixon   +2 more
openalex   +1 more source

Early and Sustained Asthma Control and Remission in Real‐World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC‐2

Clinical &Experimental Allergy, EarlyView.
Real‐world patients with severe eosinophilic asthma treated with benralizumab showed early and sustained improvements in symptoms. Clinically meaningful improvements began as early as one week after benralizumab initiation, regardless of previous biologic use, and further improved over the following year.
Erika Penz, Thomas Rothe, Lieven Dupont, Trung N. Tran, Andrew Menzies‐Gow, Anat Shavit, David Cohen, Tanja Plate, Sheena Kayaniyil, An Herreman, Claudio Schuoler, Benjamin Emmanuel, Marek Lommatzsch   +12 more
wiley   +1 more source